Cambridge Biocapital is the independent weekly newsletter covering business, funding and science news in the world-leading British biotech & VC ecosystem.

The United Kingdom biotech hub is one of the fastest growing and most rapidly changing ecosystems in the world. More than a third of all European biotech startups are established in Britain and have raised more venture capital and IPO funding than other biotech startups across Europe.

Keeping up with such dynamic scene is challenging and, until now, there was not a go-to publication for those interested in the field, from scientists to investors and entrepreneurs.